Cite
APA Citation
Bourdin, A., Papi, A. A., Corren, J., Virchow, J. C., Rice, M. S., Deniz, Y., Djandji, M., Rowe, P., & Pavord, I. D. (2021). dupilumab is effective in type 2‐high asthma patients receiving high‐dose inhaled corticosteroids at baseline. Allergy, 76(1), 269–280. http://access.bl.uk/ark:/81055/vdc_100118932183.0x000058